ANDA 91245, held by Sagent Pharms. Oxacillin Sodium.
As of Nov 15, 2026, ANDA 91245 (Oxacillin Sodium), held by Sagent Pharms, was first approved by FDA on Mar 30, 2012, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 30, 2012 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Oxacillin SodiumEQ 10GM BASE/VIAL ยท injectable;injection | Oxacillin Sodium | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
